🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchHas anyone dealt with pemvidutide phase 2? Page 2

Has anyone dealt with pemvidutide phase 2?

greg_boulder Mon, Mar 23, 2026 at 10:30 PM 6 replies 667 viewsPage 2 of 2
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Mar 24, 2026 at 8:04 PM#6
greg_boulder said:
The gap between trial results and real-world results is consistent and it is not fraud.

Forest plot interpretation for the the trial evidence meta-analysis: when reading the pooled estimate, pay attention to:

  1. Point estimate (HR/RR/OR) — center of the diamond
  2. Confidence interval width — precision of the estimate
  3. I² statistic — heterogeneity across studies
  4. Individual study weights — are results driven by one large trial?
  5. Prediction interval — range of plausible true effects in future settings

The the trial evidence meta-analysis shows a pooled RR of 0.85 (95% CI 0.67-0.90), I²=58%. This is a robust and consistent effect.

13 16pete_nash, hank_denver, carlos_SATX and 10 others
Reply Quote Save Share Report
tyler_CSCS
Member
567
2,567
Jun 2024
Phoenix, AZ
Mar 25, 2026 at 4:39 AM#7

A narrower follow-up, since the general answer is now clear:

How would you tell the difference between that and the alternative explanation?

14 17hannah_MT, Dr.SportsMedIN, amy_econ_NJ and 11 others
Reply Quote Save Share Report
sarah_TO
Member
278
1,234
Sep 2024
Toronto, CA
Mar 25, 2026 at 1:14 PM#8
SleepDoc_PDX said:
Forest plot interpretation for the the trial evidence meta-analysis: when reading the pooled estimate, pay attention to: Point estimate (HR/RR/OR) —…
SleepDoc_PDX said:
...regarding the trial evidence...

I think this is an underappreciated point. To expand on it with some data:

A recent meta-analysis of 15 RCTs (n=12,300) found that the trial evidence was associated with a clinically meaningful effect size across diverse patient populations[1].

The NNT was 12, which is comparable to statins for secondary prevention. That's a strong clinical argument for this approach.

15 18GraceAZ_72, carl_compliance, DanielChem_CHI and 12 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
greg_boulder
Member
345
1,567
Jul 2024
Boulder, CO
Mar 25, 2026 at 9:48 PM#9

Closing the loop on my own question.

Follow-up: I read the paper rather than the summary and the qualifier I was missing was in the second paragraph of the results.

Last edited: Mar 25, 2026 at 11:48 PM
16 19patPC_UT, Dr.DermMIA, fiona_VT and 13 others
Reply Quote Save Share Report
ricardo_MIA
Member
378
1,678
Sep 2024
Miami, FL
Mar 27, 2026 at 2:56 PM#10
sarah_TO said:
SleepDoc_PDX said: ...regarding the trial evidence...

Bayesian meta-analysis perspective on the trial evidence: traditional frequentist meta-analyses report point estimates and confidence intervals. Bayesian approaches provide probability distributions that are more intuitive for clinical decision-making.

For example: "There is a 98.5% probability that semaglutide 2.4mg produces >10% weight loss vs placebo" is more actionable than "RR 3.4, 95% CI 2.8-4.1, p<0.001."

The the trial evidence evidence is strong under both frameworks, but Bayesian analysis better communicates the degree of certainty for individual patient counseling.

Last edited: Mar 27, 2026 at 7:56 PM
16 16ChrisMacros, KetoKyle, CanadaChris and 13 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register